Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stella Papachristou

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
The International Journal of Lower Extremity Wounds|April 23, 2020
COVID-19 and Diabetic Foot: Will the Lamp Burn Bright?Nikolaos Papanas, Stella Papachristou
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|March 14, 2021
Reduction of Depression in Diabetes: A New Pleiotropic Action of Metformin?Stella Papachristou, Nikolaos Papanas
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|August 17, 2022
Advanced Glycation End Products: Do They Impair Bone Health in Diabetes?Stella Papachristou, Manfredi Rizzo, Nikolaos Papanas
Current Diabetes Reviews|September 1, 2021
Carpal Tunnel Syndrome in Diabetes MellitusNikolaos Papanas, Iliana Stamatiou, Stella Papachristou
Current Diabetes Reviews|March 9, 2022
Diabetes Mellitus and Bell's PalsyIliana Stamatiou, Stella Papachristou, Nikolaos Papanas
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|May 9, 2020
COVID-19 and Diabetes Mellitus: May Old Anti-diabetic Agents Become the New Philosopher's Stone?Theano Penlioglou, Stella Papachristou, Nikolaos Papanas
BMC Endocrine Disorders|February 24, 2021
Skin AGEs and diabetic neuropathyStella Papachristou, Kalliopi Pafili, Nikolaos Papanas
Diabetes/Metabolism Research and Reviews|October 9, 2021
The new dual gastric inhibitory peptide/glucagon-like peptide 1 agonist tirzepatide in type 2 diabetes: Is the future bright?Stella Papachristou, Djordje S Popovic, Nikolaos Papanas
Current Vascular Pharmacology|July 2, 2025
Glucagon-like Peptide-1 Receptor Agonists: Additional Improvement of Erectile Dysfunction in Type 2 DiabetesDjordje S Popovic, Stella Papachristou, Nikolaos Papanas
Advances in Therapy|March 28, 2022
Reduced Progression of Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma in Type 2 Diabetes Mellitus: Will Metformin Never Stop Its Pleasant Surprises?Stella Papachristou, Djordje S Popovic, Nikolaos Papanas
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
The International Journal of Lower Extremity Wounds|April 23, 2020
COVID-19 and Diabetic Foot: Will the Lamp Burn Bright?Nikolaos Papanas, Stella Papachristou
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|March 14, 2021
Reduction of Depression in Diabetes: A New Pleiotropic Action of Metformin?Stella Papachristou, Nikolaos Papanas
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|August 17, 2022
Advanced Glycation End Products: Do They Impair Bone Health in Diabetes?Stella Papachristou, Manfredi Rizzo, Nikolaos Papanas
Current Diabetes Reviews|September 1, 2021
Carpal Tunnel Syndrome in Diabetes MellitusNikolaos Papanas, Iliana Stamatiou, Stella Papachristou
Current Diabetes Reviews|March 9, 2022
Diabetes Mellitus and Bell's PalsyIliana Stamatiou, Stella Papachristou, Nikolaos Papanas
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|May 9, 2020
COVID-19 and Diabetes Mellitus: May Old Anti-diabetic Agents Become the New Philosopher's Stone?Theano Penlioglou, Stella Papachristou, Nikolaos Papanas
BMC Endocrine Disorders|February 24, 2021
Skin AGEs and diabetic neuropathyStella Papachristou, Kalliopi Pafili, Nikolaos Papanas
Diabetes/Metabolism Research and Reviews|October 9, 2021
The new dual gastric inhibitory peptide/glucagon-like peptide 1 agonist tirzepatide in type 2 diabetes: Is the future bright?Stella Papachristou, Djordje S Popovic, Nikolaos Papanas
Current Vascular Pharmacology|July 2, 2025
Glucagon-like Peptide-1 Receptor Agonists: Additional Improvement of Erectile Dysfunction in Type 2 DiabetesDjordje S Popovic, Stella Papachristou, Nikolaos Papanas
Advances in Therapy|March 28, 2022
Reduced Progression of Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma in Type 2 Diabetes Mellitus: Will Metformin Never Stop Its Pleasant Surprises?Stella Papachristou, Djordje S Popovic, Nikolaos Papanas
Pageof 3